PHARMAC’s Māori Responsiveness Strategy Action PlanMarama Parore
Ngati Whatua, Ngapuhi, Ngati Kahu
GM Access & Optimal Use – Pou Arahi Te Whaioranga
Gaps in Māori use of medicine- after adjusting for age, burden of disease (need) and relevant to the Pharmaceutical Schedule
Te Tiriti o WaitangiPHARMAC acknowledges the special relationship that exists
between the Crown and Maori, and recognises the articles of the Treaty of Waitangi; and the principles
Partnership;
Protection;
Participation.
Goal
To ensure that Māori have:
Access to subsidised medicines
The knowledge to use these medicines safely and appropriately
History of the Māori Responsiveness Strategy
2001: 15 consultation hui
2002: Māori Responsiveness Strategy I
2007-2012: Māori Responsiveness Strategy II
2012-2017: Māori Responsiveness Strategy III
“there are barriers to accessing health professionals – cost, attitude to Māori, being treated as a number”
“patients are not provided with sufficient information from chemists”
“you aren’t told everything and you can’t ask what you don’t know”
“chemist labels are confusing and hide the contents of the medicine”
“Confusion around trade names versus generic medicines”
“Medications need to be explained”
“Print on small bottles are too little to read”
“Kaumatua do not like to ask questions and are sometimes treated like they are thick”
“Māori are unsure of medicines – there is an air of mistrust and often they just need understanding”
PHARMAC survey - Key points from hui
Māori Responsiveness Strategy
– Māori strategic priorities
– Internal capability
– Data collection and analysis
– Funding and procurement
– Information on subsidised medicines and optimal use
– Māori representation and participation
• He Manawa Tahi Koiora Tini
• Cardiovascular Disease – key priority
• Tane Ora – Māori and Pacific Island men 35+ years
• Māori and Pacific Island men die of heart disease, 10-14 years earlier than non-Māori and non-Pacific Island men
• www.oneheartmanylives.co.nz
• Asthma is the leading cause of childhood admissions to hospital
• Māori and Pacific people are more likely to be hospitalised for asthma and have more severe chronic symptons
• The ratio of SABA to ICS dispensings is higher in Māori and Pacific children
• www.spacetobreathe.co.nz